CymaBay Therapeutics to Present at the 2017 BIO CEO &

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
56
CymaBay Therapeutics to Present at the 2017 BIO CEO & Investor Conference

NEWARK, Calif., Feb. 07, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY ), a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced that management will provide a corporate overview at the BIO CEO & Investor Conference, being held on February 13-14, 2017 at the Waldorf Astoria in New York City.

BIO CEO & Investor Conference Presentation Details   Date: Tuesday, February 14 Time: 9:30am Eastern Time Webcast:  http://ir.cymabay.com/events

About CymaBay CymaBay Therapeutics, Inc. (CBAY) is a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with high unmet medical need, including serious rare and orphan disorders. Seladelpar is a potent, selective, orally active PPARδ agonist. A Phase 2 study of seladelpar in patients with mixed dyslipidemia established that it has an anti-atherogenic lipid profile. CymaBay has completed Phase 2 studies for seladelpar in subjects with primary biliary cholangitis and homozygous familial hypercholesterolemia, establishing proof-of-concept in both indications. Arhalofenate, CymaBay’s other product candidate, is a potential Urate-Lowering Anti-Flare Therapy that has completed five Phase 2 studies in subjects with gout. Arhalofenate has been found to reduce painful flares in joints while at the same time lowering serum uric acid by promoting excretion of uric acid by the kidney. This dual action addresses both the signs and symptoms of gout while managing the underlying pathophysiology of hyperuricemia.  Arhalofenate has been licensed in the U.S. to Kowa Pharmaceuticals America, Inc.  CymaBay retains full development and commercialization rights for arhalofenate outside the U.S.

For additional information about CymaBay visit www.cymabay.com .

Contact: Sujal Shah CymaBay Therapeutics, Inc. (510) 293-8800 Investors@CymaBay.com Hans Vitzthum LifeSci Advisors, LLC 212-915-2568 Hans@LifeSciAdvisors.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ETERC's Ele Aims to Revolutionize STEM Education for All

Updated Category News Views 0

The AI Mentor Battleground in Education Ever found yourself wondering how public schools could step up their game without dumping money down the tech rabbit hole? ETERC’s latest push with Ele may just be a game-changer for them. We're not talking about your run-of-the-mill chatbot regurgitating facts from the internet—this is an AI tricked out for personalized...

Continue Reading
Debt Crisis Looms: Social Security at Risk

Updated Category News Views 0

Debt Reality: A National Concern with Global Implications When it comes to the U.S. federal debt situation, the latest report from the National Seniors Policy Center is lighting a fire like no other, warning us that we're not crying wolf here. We've got fiscal numbers that may not sit well at breakfast. With roughly 67 cents of every new buck Uncle Sam borrows going to...

Continue Reading
IRS Views Challenge Tax-Engineered Healthcare Schemes

Updated Category News Views 0

Nonprofit Models Shine Amid IRS Scrutiny Out in Oxnard, California, there's a brewing storm in the healthcare sector. No, it's not a billing error or yet another scandal. We're talking about a seismic shift that could poke holes in those tax-engineered Section 105(b) programs, all thanks to some hard-hitting IRS memoranda. The Nonprofit–TPA Model: A Safer Bet? Enter...

Continue Reading
Wounded Warrior Project Honors Veterans at Gala Dinner

Updated Category News Views 0

Wounded Warriors Gala: A Night of Heroic Honors In the swirling hum of Washington's gala scene, the Wounded Warrior Project (WWP) cuts through the noise with a sharp and poignant reminder of patriotism and community support. Their Courage Awards & Benefit Dinner®, pumped with the gravitas of corporate backing from the likes of Goldman Sachs, showcased a heartfelt...

Continue Reading
Celebrate National Service Dog Month with Canine Companions

Updated Category News Views 2

A Month to Celebrate Unseen Heroes Take a pause. We're talking about National Service Dog Month. What in the world could be more endearing than a pack of puppies, those hopeful bundles of joy, destined to grow up and play pivotal roles in people's lives? Canine Companions is rolling out the red carpet for these future heroes, with a nine-day Puppy Cam event from September...

Continue Reading
Buffett Steps Down, New Faces at Berkshire Hathaway

Updated Category News Views 2

End of an Era: Warren Buffett's Retirement Warren Buffett—there's a name that's echoed through the halls of investment for decades. Today, he's pulling down the curtain as Chairman of Berkshire Hathaway (NYSE: BRK). No fanfare, just a nod to the inevitable with his classic, humor-tinged confession: 'Father Time always wins.' Can’t argue with the man who’s seen the...

Continue Reading
Digital Wine Atlas Maps 4.3 Million Vineyards Globally

Updated Category News Views 2

Revolutionizing Viticulture with Data In today's wild world, climate change isn't just shifting weather patterns—it's upending the age-old map of wine-making regions. We've got a new player on the field: the World Winery Map. It's digital, massive, and it’s shaking things up for winemakers and grape enthusiasts alike. This platform covers a staggering 4.3 million...

Continue Reading
Bascom's Strategic Play on a Dallas Apartment Deal

Updated Category News Views 0

Unpacking Bascom's Jasmine Acquisition In a market that's been more slippery than a greased pig, Bascom Group's move buying up Jasmine Apartments is capturing some eyes. Situated in North Dallas, this 370-unit complex ain't just another brick in the wall—it's Bascom's 42nd entry into Texas, reinforcing their knack for sniffing out deals others might tiptoe around,...

Continue Reading
Sierra Ridge Advisors Join Gateway Financial Milestone

Updated Category News Views 2

Big Moves in the Financial Advisory World Let's dive right in. Here's a real shakeup in the advisory realm: 28 financial advisors and team members from Sierra Ridge Advisor Group are packing their bags for Gateway Financial Partners. We're talking about a significant shift involving $825 million in assets under advisement. Instead of sticking with Sierra Ridge as it...

Continue Reading
Bellissima Bags Allure Award for Curly Hair Tool

Updated Category News Views 0

Award-Winning Tool Headlines 2026 Beauty Scene There's a shake-up in the world of hair tools, folks. Bellissima's Diffon Supreme has snagged a 2026 Allure Best of Beauty Award for its prowess in taming the curly, wavy, and coily strands we all crave to manage. Performance Meets Innovation in Bellissima's Latest Let's not beat around the bush. The Diffon Supreme's trump...

Continue Reading

Top 5 Most Recently Viewed Articles

Outstanding Real Estate Achievements of Pettingell Professionals

Updated Category News Views 185

Celebrating the Triumphs of Pettingell Professionals Coldwell Banker Realty is delighted to share the impressive accomplishments of Roger Pettingell and his esteemed team, the Pettingell Professionals, who achieved a remarkable milestone in closed sales for the year. With achievements showcasing over $221 million in sales volume in a recent year, the team has rightfully...

Continue Reading
Envista Holdings Corp: An Insight Into Market Trends

Updated Category News Views 175

Understanding Envista Holdings Corp's Market Dynamics Envista Holdings Corp (NYSE: NVST) has witnessed notable movements in its short interest percentage recently. The figure has seen a decline of 11.19% from the last available report, indicating a shift in market sentiment. Currently, there are approximately 9.10 million shares sold short, representing 6.67% of the...

Continue Reading
Exploring Recent Trends in Humana Options Activity

Updated Category News Views 158

Understanding the Current Options Trends for Humana Investors have been showing increased interest in Humana (NYSE: HUM), indicating a bullish sentiment among those willing to invest substantial capital. It's important for retail traders to stay informed about these movements. Today's analysis reveals a noteworthy pattern in options trading for Humana, as seen in the...

Continue Reading
Christine Russell's Stock Options Move at eGain: What You Should Know

Updated Category News Views 170

Christine Russell's Stock Option Exercise at eGain In a recent filing with the SEC, it was disclosed that Christine Russell, a Board Member at eGain, executed an options exercise that ended up realizing no monetary gain due to the exercise price being set at $0.0. This move raised eyebrows among investors as it was worth 0 shares of the company, painted against eGain's...

Continue Reading
Unlocking Crypto Trading: 100x Leverage and Bonuses Await

Updated Category News Views 154

Trade Smarter with BexBack's 100x Leverage As the cryptocurrency market continues to evolve, investors are always on the lookout for strategies that can yield significant returns. With current fluctuations in Bitcoin prices, which hover below $100,000, trading dynamics are continually shifting. This creates an environment ripe for volatility, and for savvy traders, the...

Continue Reading